Chemill Launches Clinically Proven Nitric Oxide Nasal Spray – VirX™ in Hong Kong A Safe Antiviral Treatment Killing 99.9% Virus in 2 Minutes to Fight the Pandemic Virus
Media Outreach
Clinical Trials in Canada, India and U.K. Confirm the Efficacy
HONG KONG SAR – Media OutReach – 18 July 2022 –Chemill Pharma Ltd, today announced the launch of a clinically proven and safe nitric oxide nasal spray (NONS), under the brand name VirX™ for prevention against the pandemic virus, in Hong Kong.Developed and patented by SaNOtize Research in Canada, the nasal spray, containing nitric oxide, can be delivered in small amount into a person’s nasal cavity, thus killing 99.9% viruses in the respiratory upper airways within 2 minutes. Its proven anti-microbial properties with a direct virucidal effect on SARS-CoV-2 help reduce viral load and act as a physical and chemical barrier to prevent viruses from incubating and spreading to the lungs.